Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system

35Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Molecular targeting of hematopoietic malignancies has been generally hindered by technological obstacles to gene delivery in the neoplastic cells. The development of peptide delivery systems based on protein transduction domains has recently gained attention as a means of potentially overcoming these impediments. Here, we present a novel peptide transporter system that increases the efficiency of peptide delivery more than 10 times compared with the previous methods. The transporter, Wr-T, has an enlarged hydrophobic pocket consisting of triple tryptophan-rich domains fused with nine D-enantiomer polyarginines (r9) via Gly-Pro-Gly spacer, which serves to augment delivery of a cargo peptide. Wr-T-mediated transport of p16INK4a functional peptide dramatically inhibits growth of highly aggressive leukemia/lymphomas by up to 80% through restoration of p16 function. The Wr-T system thus represents a highly effective approach to cargo peptide delivery with the potential for substantially developing p16 peptide-based therapy for hematopoietic malignancies. Copyright © 2004 American Association for Cancer Research.

References Powered by Scopus

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters

1497Citations
N/AReaders
Get full text

A peptide carrier for the delivery of biologically active proteins into mammalian cells

940Citations
N/AReaders
Get full text

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27(Kip1) induces cell migration

903Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

140Citations
N/AReaders
Get full text

Protein nanoparticles for therapeutic protein delivery

118Citations
N/AReaders
Get full text

Therapeutic peptides for cancer therapy. Part II - Cell cycle inhibitory peptides and apoptosis-inducing peptides

47Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kondo, E., Seto, M., Yoshikawa, K., & Yoshino, T. (2004). Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system. Molecular Cancer Therapeutics, 3(12), 1623–1630. https://doi.org/10.1158/1535-7163.1623.3.12

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

54%

Researcher 7

29%

Professor / Associate Prof. 2

8%

Lecturer / Post doc 2

8%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 14

56%

Chemistry 5

20%

Biochemistry, Genetics and Molecular Bi... 4

16%

Medicine and Dentistry 2

8%

Save time finding and organizing research with Mendeley

Sign up for free